Development and validation of an LC-MS-MS method for the determination of terfenadine in human plasma

被引:17
作者
Xu, A
Linderholm, K
Peng, L
Hulse, J
机构
[1] Harris Laboratories, Lincoln, NE 68501
关键词
LC-MS-MS; terfenadine; antihistamine;
D O I
10.1016/0731-7085(96)01804-3
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
A sensitive LC-MS-MS method capable of quantifying terfenadine at levels down to 100 pg ml(-1) in human plasma is reported. The method was validated over a linear range from 0.1 to 5.0 ng ml(-1) using a liquid-liquid extraction with a deuterium-labelled internal standard. The between-run precision and accuracy of the calibration standards were 2.6-6.0% RSD and -2.0 to +2.2%, relative error (RE). The between-run and within-run precision and accuracy of quality control samples (0.3, 1.5 and 3.5 ng ml(-1)) were 1.0-5.9% RSD and +1.7 to +6.3% RE. This method was applied to the analysis of human plasma samples.
引用
收藏
页码:1675 / 1680
页数:6
相关论文
共 7 条
[1]  
CHEN T, 1992, J PHARM BIOMED ANAL, V9, P929
[2]   RADIOIMMUNOASSAY FOR TERFENADINE IN HUMAN-PLASMA [J].
COOK, CE ;
WILLIAMS, DL ;
MYERS, M ;
TALLENT, CR ;
LEESON, GA ;
OKERHOLM, RA ;
WRIGHT, GJ .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1980, 69 (12) :1419-1423
[3]   DETERMINATION OF TERFENADINE AND TERFENADINE ACID METABOLITE IN PLASMA USING SOLID-PHASE EXTRACTION AND HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY WITH FLUORESCENCE DETECTION [J].
COUTANT, JE ;
WESTMARK, PA ;
NARDELLA, PA ;
WALTER, SM ;
OKERHOLM, RA .
JOURNAL OF CHROMATOGRAPHY-BIOMEDICAL APPLICATIONS, 1991, 570 (01) :139-148
[4]  
GARTEIZ DA, 1982, ARZNEIMITTEL-FORSCH, V32-2, P1185
[5]   BIOAVAILABILITY OF TERFENADINE IN MAN [J].
OKERHOLM, RA ;
WEINER, DL ;
HOOK, RH ;
WALKER, BJ ;
LEESON, GA ;
BIEDENBACH, SA ;
CAWEIN, MJ ;
DUSEBOUT, TD ;
WRIGHT, GJ ;
MYERS, M ;
SCHINDLER, V ;
COOK, CE .
BIOPHARMACEUTICS & DRUG DISPOSITION, 1981, 2 (02) :185-190
[6]  
RODRIGUES AD, 1995, DRUG METAB DISPOS, V23, P765
[7]   TERFENADINE - A REVIEW OF ITS PHARMACODYNAMIC PROPERTIES AND THERAPEUTIC EFFICACY [J].
SORKIN, EM ;
HEEL, RC .
DRUGS, 1985, 29 (01) :34-56